edited by Shahbudin H. Rahimtoola (Cardiovasc Clin, vol 13, No. 1, Albert N. Brest, ed-in-chief), 367 pp, 140 illus, $45, Philadelphia, FA Davis Co, 1983.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This book is recommended for reading by internists and general practitioners as well as by cardiologists. It represents the state of the art in coronary cardiology at the present time. "Frontiers" rather than "controversies" would have been more appropriate in the title, since there is no controversial discussion among adversaries.
Like all such multiauthored books, some chapters are better written and more acceptable than others, and, because of rapid development in the field, some chapters are already out of date. For example, diltiazem hydrochloride, now generally available, is not discussed along with the other calcium blockers.
In my opinion, the book is also out of balance and underemphasizes prevention. The one chapter on prevention deals largely with cholesterol and lipids, skimpily with hypertension, and not at all with exercise and behavioral modification.
The chapters on noninvasive screening are superb, and those on intravascular thrombolysis as well as balloon dilatation are
Mendlowitz M. Controversies in Coronary Artery Disease. JAMA. 1983;249(9):1201-1202. doi:10.1001/jama.1983.03330330079047